4//SEC Filing
Kayitalire Louis 4
Accession 0001209191-22-002921
CIK 0001566373other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 5:32 PM ET
Size
5.9 KB
Accession
0001209191-22-002921
Insider Transaction Report
Form 4
Kayitalire Louis
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-09+53,634→ 53,634 totalExercise: $4.77Exp: 2032-01-09→ Common Stock (53,634 underlying)
Footnotes (2)
- [F1]These options were granted under the Issuer's 2019 Equity Incentive Plan.
- [F2]Twenty five percent (25%) of the total number of shares under the award shall vest on the first anniversary of the Vesting Commencement Date, January 9, 2022, and thereafter in 36 equal monthly installments such that the stock option shall be fully-vested on the fourth annual anniversary of the Vesting Commencement Date.
Documents
Issuer
F-star Therapeutics, Inc.
CIK 0001566373
Entity typeother
Related Parties
1- filerCIK 0001831519
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 5:32 PM ET
- Size
- 5.9 KB